Please assess the completion status of the following clinical trial:

Trial Title: Tegarderm® Placement for Bag Mask Ventilation in the Bearded Patient

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients with perioral facial hair \>5mm in length~* Undergoing elective non-cardiac surgery with planned bag-mask ventilation during anesthesia induction~Exclusion Criteria:~* Known allergy to Tegaderm product and/or its adhesive~* Emergency surgery~* Active or unstable cardiac disease~* ASA (American Society of Anesthesiologists) physical status ≥4~* External or internal active airway obstruction from tumor, abscess, or laryngeal edema~* Organic or non-organic oropharyngeal anatomical defects including history of radiation treatment to the neck~* Moderate to severe acute and chronic restrictive or obstructive lung diseases, e.g. chronic obstructive pulmonary disease, asthma, etc.~* Requirement for rapid sequence intubation, or known aspiration risk~* Cervical spine injury~* Previously documented difficult mask ventilation or intubation~* BMI ≥50~* Vulnerable populations: children, prisoners, pregnant patients, cognitively impaired adults

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Bag-Mask Ventilation with Tegaderm (Type: EXPERIMENTAL): Patients will receive bag-mask ventilation with Tegaderm placement
- Bag-Mask Ventilation without Tegaderm (Type: ACTIVE_COMPARATOR): Patients will receive bag-mask ventilation without Tegaderm placement

Based on this trial design, predict the completion outcome and termination type (if applicable).